US Stock MarketDetailed Quotes

NKTR Nektar Therapeutics

Watchlist
  • 1.0100
  • +0.0100+1.00%
Close Dec 13 16:00 ET
  • 1.0300
  • +0.0200+1.98%
Post 20:01 ET
186.30MMarket Cap-1.20P/E (TTM)

Nektar Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-4.30%-43.93M
26.82%-37.7M
7.76%-47.89M
36.64%-192.61M
18.47%-47.05M
49.18%-42.12M
31.30%-51.52M
41.29%-51.92M
26.33%-304.01M
61.92%-57.7M
Net income from continuing operations
19.15%-37.06M
-2.43%-52.36M
73.14%-36.8M
25.03%-276.06M
29.50%-42.08M
22.37%-45.84M
67.86%-51.12M
-51.58%-137.02M
29.71%-368.2M
59.02%-59.69M
Operating gains losses
----
----
----
117.41%6.4M
----
----
----
----
-558.10%-36.75M
-968.41%-3.33M
Depreciation and amortization
-41.42%993K
-32.64%1.46M
-30.19%1.61M
-40.02%7.82M
-48.08%1.65M
-36.68%1.7M
-37.05%2.17M
-38.28%2.3M
-7.89%13.03M
-7.39%3.18M
Deferred tax
-106.67%-31K
311.11%57K
97.90%-38K
-105.17%-140K
-36.71%1.71M
---15K
---27K
---1.81M
2,754.90%2.71M
--2.71M
Other non cash items
20.77%-9.71M
-11.72%-7.32M
4.01%-13.04M
-21.30%-43.59M
-7.37%-11.19M
-1.39%-12.26M
31.85%-6.55M
-257.03%-13.59M
-436.44%-35.93M
-180.28%-10.43M
Change In working capital
133.83%1.09M
215.42%10.8M
-167.62%-6.62M
-4,124.39%-19.8M
41.35%-4.73M
88.36%-3.23M
-142.89%-9.36M
-117.05%-2.47M
102.14%492K
84.40%-8.07M
-Change in receivables
2.19%-850K
45.84%2.42M
-180.78%-2.41M
-71.07%4.78M
-82.00%999K
43.05%-869K
-91.79%1.66M
138.64%2.99M
33.19%16.51M
121.86%5.55M
-Change in inventory
-94.80%123K
128.12%212K
42.42%-1.14M
120.55%699K
838.62%1.07M
213.36%2.37M
52.58%-754K
-570.38%-1.99M
-568.17%-3.4M
69.21%-145K
-Change in payables and accrued expense
716.19%8.82M
162.14%6.62M
111.92%868K
-18.78%-20.01M
77.82%-3.16M
105.85%1.08M
-742.25%-10.65M
-142.41%-7.28M
51.34%-16.84M
54.61%-14.26M
-Change in other current assets
-3.65%-3.58M
20.86%2.79M
-117.46%-976K
-48.12%3.58M
-142.40%-867K
-24.80%-3.45M
-51.48%2.31M
95.22%5.59M
367.05%6.91M
160.15%2.05M
-Change in other working capital
-45.02%-3.42M
35.89%-1.24M
-65.62%-2.96M
-230.22%-8.85M
-120.53%-2.77M
18.84%-2.36M
-541.53%-1.93M
-199.94%-1.79M
-214.53%-2.68M
93.36%-1.26M
Cash from discontinued investing activities
Operating cash flow
-4.30%-43.93M
26.82%-37.7M
7.76%-47.89M
36.64%-192.61M
18.47%-47.05M
49.18%-42.12M
31.30%-51.52M
41.29%-51.92M
26.33%-304.01M
61.92%-57.7M
Investing cash flow
Cash flow from continuing investing activities
-18.25%46.12M
-32.53%16.98M
-52.56%19.26M
-61.85%139.56M
-56.56%17.38M
-49.36%56.41M
-70.09%25.17M
-68.84%40.6M
80.41%365.84M
-66.71%40.01M
Net PPE purchase and sale
-154.95%-666K
-14.81%-186K
63.74%-157K
-94.95%380K
-101.87%-237K
769.61%1.21M
79.23%-162K
89.70%-433K
150.17%7.52M
315.13%12.68M
Net investment purchase and sale
-15.25%46.78M
-32.23%17.17M
-52.68%19.42M
-61.16%139.18M
-35.53%17.62M
-50.53%55.2M
-70.17%25.33M
-69.49%41.03M
64.54%358.32M
-78.33%27.33M
Cash from discontinued investing activities
Investing cash flow
-18.25%46.12M
-32.53%16.98M
-52.56%19.26M
-61.85%139.56M
-56.56%17.38M
-49.36%56.41M
-70.09%25.17M
-68.84%40.6M
80.41%365.84M
-66.71%40.01M
Financing cash flow
Cash flow from continuing financing activities
13K
5.56%19K
42M
-98.01%30K
-88.35%12K
0
-96.15%18K
0
-95.84%1.51M
-95.96%103K
Net common stock issuance
--0
--0
---3M
----
----
--0
--0
--0
----
----
Proceeds from stock option exercised by employees
--13K
5.56%19K
--30M
-96.04%30K
-88.35%12K
--0
-96.15%18K
--0
-97.72%758K
-94.28%103K
Net other financing activities
--0
--0
--15M
----
----
----
----
----
-75.00%750K
--0
Cash from discontinued financing activities
Financing cash flow
--13K
5.56%19K
--42M
-98.01%30K
-88.35%12K
--0
-96.15%18K
--0
-95.84%1.51M
-95.96%103K
Net cash flow
Beginning cash position
-44.92%27.94M
-36.79%48.64M
-60.02%35.28M
249.86%88.23M
-38.61%64.92M
-34.58%50.73M
13.18%76.96M
249.86%88.23M
-87.32%25.22M
95.79%105.76M
Current changes in cash
-84.63%2.2M
21.39%-20.7M
218.17%13.37M
-183.70%-53.01M
-68.61%-29.65M
-49.87%14.29M
-373.69%-26.33M
-126.45%-11.32M
136.47%63.34M
38.91%-17.59M
Effect of exchange rate changes
71.43%-28K
-100.93%-1K
-117.78%-8K
118.96%62K
-85.45%8K
66.78%-98K
252.86%107K
364.71%45K
-255.43%-327K
650.00%55K
End cash Position
-53.62%30.11M
-44.92%27.94M
-36.79%48.64M
-60.02%35.28M
-60.02%35.28M
-38.61%64.92M
-34.58%50.73M
13.18%76.96M
249.86%88.23M
249.86%88.23M
Free cash flow
-5.80%-44.6M
26.69%-37.89M
8.22%-48.05M
37.53%-193.47M
18.78%-47.28M
49.25%-42.15M
31.79%-51.69M
43.49%-52.35M
27.58%-309.68M
63.02%-58.22M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -4.30%-43.93M26.82%-37.7M7.76%-47.89M36.64%-192.61M18.47%-47.05M49.18%-42.12M31.30%-51.52M41.29%-51.92M26.33%-304.01M61.92%-57.7M
Net income from continuing operations 19.15%-37.06M-2.43%-52.36M73.14%-36.8M25.03%-276.06M29.50%-42.08M22.37%-45.84M67.86%-51.12M-51.58%-137.02M29.71%-368.2M59.02%-59.69M
Operating gains losses ------------117.41%6.4M-----------------558.10%-36.75M-968.41%-3.33M
Depreciation and amortization -41.42%993K-32.64%1.46M-30.19%1.61M-40.02%7.82M-48.08%1.65M-36.68%1.7M-37.05%2.17M-38.28%2.3M-7.89%13.03M-7.39%3.18M
Deferred tax -106.67%-31K311.11%57K97.90%-38K-105.17%-140K-36.71%1.71M---15K---27K---1.81M2,754.90%2.71M--2.71M
Other non cash items 20.77%-9.71M-11.72%-7.32M4.01%-13.04M-21.30%-43.59M-7.37%-11.19M-1.39%-12.26M31.85%-6.55M-257.03%-13.59M-436.44%-35.93M-180.28%-10.43M
Change In working capital 133.83%1.09M215.42%10.8M-167.62%-6.62M-4,124.39%-19.8M41.35%-4.73M88.36%-3.23M-142.89%-9.36M-117.05%-2.47M102.14%492K84.40%-8.07M
-Change in receivables 2.19%-850K45.84%2.42M-180.78%-2.41M-71.07%4.78M-82.00%999K43.05%-869K-91.79%1.66M138.64%2.99M33.19%16.51M121.86%5.55M
-Change in inventory -94.80%123K128.12%212K42.42%-1.14M120.55%699K838.62%1.07M213.36%2.37M52.58%-754K-570.38%-1.99M-568.17%-3.4M69.21%-145K
-Change in payables and accrued expense 716.19%8.82M162.14%6.62M111.92%868K-18.78%-20.01M77.82%-3.16M105.85%1.08M-742.25%-10.65M-142.41%-7.28M51.34%-16.84M54.61%-14.26M
-Change in other current assets -3.65%-3.58M20.86%2.79M-117.46%-976K-48.12%3.58M-142.40%-867K-24.80%-3.45M-51.48%2.31M95.22%5.59M367.05%6.91M160.15%2.05M
-Change in other working capital -45.02%-3.42M35.89%-1.24M-65.62%-2.96M-230.22%-8.85M-120.53%-2.77M18.84%-2.36M-541.53%-1.93M-199.94%-1.79M-214.53%-2.68M93.36%-1.26M
Cash from discontinued investing activities
Operating cash flow -4.30%-43.93M26.82%-37.7M7.76%-47.89M36.64%-192.61M18.47%-47.05M49.18%-42.12M31.30%-51.52M41.29%-51.92M26.33%-304.01M61.92%-57.7M
Investing cash flow
Cash flow from continuing investing activities -18.25%46.12M-32.53%16.98M-52.56%19.26M-61.85%139.56M-56.56%17.38M-49.36%56.41M-70.09%25.17M-68.84%40.6M80.41%365.84M-66.71%40.01M
Net PPE purchase and sale -154.95%-666K-14.81%-186K63.74%-157K-94.95%380K-101.87%-237K769.61%1.21M79.23%-162K89.70%-433K150.17%7.52M315.13%12.68M
Net investment purchase and sale -15.25%46.78M-32.23%17.17M-52.68%19.42M-61.16%139.18M-35.53%17.62M-50.53%55.2M-70.17%25.33M-69.49%41.03M64.54%358.32M-78.33%27.33M
Cash from discontinued investing activities
Investing cash flow -18.25%46.12M-32.53%16.98M-52.56%19.26M-61.85%139.56M-56.56%17.38M-49.36%56.41M-70.09%25.17M-68.84%40.6M80.41%365.84M-66.71%40.01M
Financing cash flow
Cash flow from continuing financing activities 13K5.56%19K42M-98.01%30K-88.35%12K0-96.15%18K0-95.84%1.51M-95.96%103K
Net common stock issuance --0--0---3M----------0--0--0--------
Proceeds from stock option exercised by employees --13K5.56%19K--30M-96.04%30K-88.35%12K--0-96.15%18K--0-97.72%758K-94.28%103K
Net other financing activities --0--0--15M---------------------75.00%750K--0
Cash from discontinued financing activities
Financing cash flow --13K5.56%19K--42M-98.01%30K-88.35%12K--0-96.15%18K--0-95.84%1.51M-95.96%103K
Net cash flow
Beginning cash position -44.92%27.94M-36.79%48.64M-60.02%35.28M249.86%88.23M-38.61%64.92M-34.58%50.73M13.18%76.96M249.86%88.23M-87.32%25.22M95.79%105.76M
Current changes in cash -84.63%2.2M21.39%-20.7M218.17%13.37M-183.70%-53.01M-68.61%-29.65M-49.87%14.29M-373.69%-26.33M-126.45%-11.32M136.47%63.34M38.91%-17.59M
Effect of exchange rate changes 71.43%-28K-100.93%-1K-117.78%-8K118.96%62K-85.45%8K66.78%-98K252.86%107K364.71%45K-255.43%-327K650.00%55K
End cash Position -53.62%30.11M-44.92%27.94M-36.79%48.64M-60.02%35.28M-60.02%35.28M-38.61%64.92M-34.58%50.73M13.18%76.96M249.86%88.23M249.86%88.23M
Free cash flow -5.80%-44.6M26.69%-37.89M8.22%-48.05M37.53%-193.47M18.78%-47.28M49.25%-42.15M31.79%-51.69M43.49%-52.35M27.58%-309.68M63.02%-58.22M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data